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hransaortic septal myectomy is currently considered to
be the most appropriate surgical treatment for pa-
ients with obstructive hypertrophic cardiomyopathy
HCM) and severe symptoms unresponsive to medical
herapy.1-18 However, there is a significant learning curve
or this procedure, and early surgical experience was as-
ociated with complications of complete heart block, ven-
ricular septal defect, injury to the aortic or mitral valves,
nd incomplete relief of obstruction. Current surgical re-
ults are vastly improved, although the reported experi-
nce in North America is limited to a few centers.
urgical Technique
ver the last three decades, our technique of septal myec-
omy has evolved from the classic Morrow myectomy (Fig
A) to a more extended left ventricular septal myectomy
Fig 1B).
Intraoperative transesophageal echocardiography (TEE)
s performed after induction of general anesthesia, with
articular attention to the cardiac anatomy, mitral valve
unction, and appearance of the ventricular septum. Im-
ortant information obtained from TEE includes the max-
mum thickness of the septum, the distance of maximum
hickness from the aortic annulus, the location of the en-
ocardial fibrous plaque (friction lesion), and the apical
xtent of the septal bulge. Exposure is gained through a
edian sternotomy and pressures are measured in all four
ardiac chambers and aorta. If the right ventricular pres-
ure is elevated, pulmonary arterial pressure is also mea-
ured to evaluate possible right ventricular outflow tract
bstruction or pulmonary hypertension. If the left ventric-
lar outflow tract (LVOT) gradient is low (30 mmHg)
ecause of the conditions under anesthesia, provocation
ith an isoproterenol infusion is performed. Documenta-
ayo Clinic, Rochester, MN.
ddress reprint requests to Joseph A. Dearani, MD, Mayo Clinic, Section ofpCardiothoracic Surgery, 200 First Street SW, Rochester, MN 55905.
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doi:10.1053/j.optechstcvs.2004.11.001ion of the LVOT gradient is important so that a compar-
son can be made with postmyectomy measurements.
tandard cardiopulmonary bypass with mild to moderate
ypothermia (30-34°C) is used and the left heart is vented
ith a catheter inserted through the right superior pulmo-
ary vein. Myocardial protection, especially important be-
ause of the severe ventricular hypertrophy, is begun with
generous infusion of cold blood cardioplegia (800-1000
L) into the aortic root followed by additional doses given
electively into the left and right coronary ostia every 20
inutes. For more complex and lengthy procedures, top-
cal cooling with ice-cold saline is applied, and an insulat-
ng pad is placed behind the left ventricle.
After the extended left ventricular septal myectomy is
erformed, the resected area can be deepened with a ron-
eur. Direct inspection and digital palpation evaluate the
dequacy and distal extent of the resection. The most com-
on reasons for residual gradients are inadequate septec-
omy at midventricular level and overlooking anomalous
apillary muscles.17 In general, one can visualize the pap-
llary muscles and chordae while looking through the aor-
ic root after the myectomy has been completed. The left
entricle is irrigated to remove any particulate debris and
he aortic and mitral valves are inspected to insure that
here has been no injury to them. After the patient is
eaned from cardiopulmonary bypass, pressures are re-
easured in the left ventricle and aorta and TEE evalua-
ion is repeated. TEE can quantify and localize any resid-
al LVOT gradient or mitral regurgitation and can exclude
ny iatrogenic ventricular septal defect. If successful my-
ctomy has been performed, there will be little or no re-
idual gradient and little or no systolic anterior motion of
he anterior mitral leaflet. In general, we would resume
ardiopulmonary bypass for further resection if the gradi-
nt were greater than 15 to 20 mmHg. Transthoracic echo-
ardiographic evaluation is routinely performed before
ospital discharge.
Measurements and distances given in the figure legends
ertain to the adult patient (Figs 1-15).
Transaortic septal myectomy 279Figure 1 Upper panel, Obstructive hypertrophic cardiomyopathy with basal and midventricular obstruction. (A)
ClassicMorrow procedure. (B) Extended septal myectomy. Note leftward extension that includes resection from the left
ventricular free wall. White arrows indicate rightward and midventricular resections. The endocardial fibrous plaque
(friction lesion) shows the location of systolic contact of the anterior mitral leaflet with the septum. Lines in the basal
septum represent fascicles of the left bundle originating from the membranous septum.
280 J.A. Dearani and G.K. DanielsonFigure 2 A transverse aortotomy is made and carried down toward the middle of the noncoronary sinus (dashed line).
The aortotomy is carried to within 0.5 to 1.0 cm of the aortic annulus.
Transaortic septal myectomy 281Figure 3 A vein retractor is used to engage the right aortic sinus. Suspension sutures of pledgeted 4.0 prolene are placed
a few millimeters above the aortic valve commissures to maximize exposure of the hypertrophied septum and anterior
mitral leaflet.
282 J.A. Dearani and G.K. DanielsonFigure 4 Optimal visualization of the ventricular septum is facilitated by posterior displacement of the anterior wall of
the left ventricle with a sponge forceps (arrow). A small Yankauer suction cannula is placed across the aortic annulus
to retract the anterior mitral leaflet and papillary muscles posteriorly and rightward away from the ventricular septum.
A closed forceps is used to retract the left coronary cusp. Inspection of the anatomy is performed including identifi-
cation of the friction lesion. For optimum accuracy, methylene blue can be used to mark the initial incision lines.
Frequent repositioning of the sponge forceps and suction cannula is critical for maintaining exposure of the desired
areas of resection.
Transaortic septal myectomy 283Figure 5 The vein retractor is moved to engage and protect the right coronary cusp from injury. The classical portion of
the resection is begun by beginning the first longitudinal incision at midventricular level (see inset) and extending it
upward to within 8 to 10 mm of the nadir of the annulus of the right coronary cusp. It is important to leave 8 to 10 mm
of muscle immediately below the aortic annulus to prevent subsequent development of cusp prolapse and aortic
regurgitation. This is usually done with a #10 or #12 blade. Care is taken to begin this incision apically well below the
friction lesion. Any incision made at the base of the ventricular septummore rightward than the nadir of the right cusp
will injure the membranous septum and conduction tissue and result in complete heart block. RCC, right coronary
cusp. (Traction sutures are omitted for clarity.)
284 J.A. Dearani and G.K. DanielsonFigure 6 A second longitudinal incision, parallel to the first incision, is begun at the midventricular level and carried up
to 8 to 10 mm below the plane of the aortic annulus at the commissure between the left and right cusps. The area to the
left of this incision is left ventricular free wall.
Transaortic septal myectomy 285Figure 7 The two incisions are joined superiorly. The vein retractor is now moved to engage the aortic annulus in the
trough where the two incisions were joined. A small rake retractor or hook (see Fig 10) can be used to engage the distal
septum so that it can be pulled cephalad toward the aortic annulus. A deep wedge of left ventricular septum is then
resected by beginning at the base of the septum and working toward the midventricle. In general, the thickness of the
resected muscle is two-thirds the thickness of septum (as measured by prebypass TEE images), while ensuring that the
retained septum is at least 1 cm thick. Retractors are moved accordingly to prevent injury to surrounding structures.
This completes the classical portion of the resection.
2Figure 8 (A) After the classical portion of the resection is completed, the resection is then extended leftward. Because the
friction lesion, when present, represents the area of obstruction, it is important to include this in the resection whenever
feasible. There is usually a bulge of muscle located between the commissure of the right and left cusps and the anterior
mitral leaflet (within the dotted line). Improved exposure of this bulge can be accomplished by rightward traction with
a Selman forceps. Hypertrophied muscle in this area is part of the left ventricular free wall. It is important to know the
thickness of the free wall (obtained by TEE) to avoid excessive resection in this area with resultant perforation of the
heart. (B) The completed leftward resection. It is important to also extend this resection down into the ventricle to the
86 J.A. Dearani and G.K. Danielsonlevel of the bases of the papillary muscles.
Transaortic septal myectomy 287Figure 9 Exposure of the right side of the ventricular septum is facilitated by repositioning the sponge forceps on the
outside of the heart, often near the acute margin of the right ventricle (black arrow). The suction cannula is again used
to retract the mitral valve chordae and papillary muscles out of the way so that exposure of this rightward septum is
optimized.
288 J.A. Dearani and G.K. DanielsonFigure 10 This figure demonstrates a close-up of the exposure of the rightward portion of the septum. There is 2.5 to 3.0
cm of muscle maintained below the level of the membranous septum, which is the location of the conduction tissue
(inset). Engaging the distal aspect of the septum with a small rake or hook retractor can also facilitate exposure of this
rightward portion of the resection. The septum is pulled cephalad toward the aortic annulus in addition to the sponge
forceps pushing the septum from outside the heart. All bulging septal muscle apical to this area and rightward to the
initial classical resection is resected, effectively making the trough much wider at the apex than at the base of the heart
(inset).
Transaortic septal myectomy 289Figure 11 After the classical and extended portions of the resection are completed, inspection of the subvalvar apparatus
for mitral valve abnormalities is performed. One of the more common abnormalities, which is depicted in this figure,
shows the direct insertion of the head of the often large anterolateral papillary muscle into the anterior leaflet of the
mitral valve. The muscle insertion site is frequently adjacent to the commissure of the mitral valve. In addition to direct
insertion of the papillary muscle into the anterior leaflet, there is often concomitant fusion of the papillary muscle to the
left ventricular septum or free wall. In addition to the extended septal myectomy as previously described, the papillary
muscle is incised off the left ventricular septum or free wall down to its base (inset).19 This maneuver is important so
that the papillary muscle can move out of the left ventricular outflow tract during systole and thus avoid creating LVOT
obstruction.
290 J.A. Dearani and G.K. DanielsonFigure 12 This figure demonstrates examples of the many abnormal chordal and subvalvar attachments that can occur
in the setting of hypertrophic cardiomyopathy. There can be fibrous attachments between the side of the anterior mitral
leaflet and the ventricular septum or free wall. In addition, there can be additional (accessory) papillary muscles or
chordae that join the anterolateral papillary muscle to the ventricular septum. These abnormalities are also addressed
at the time of myectomy because they can contribute to LVOT obstruction because of the inability of the anterior leaflet
and/or papillary muscle and subvalvar apparatus to move out of the LVOT during systole.Figure 13 (A) This figure demonstrates the basic surgical principle that is applied to all of these abnormalities. It is
important to maintain intact all attachments that come to the leading edge of the anterior mitral leaflet. This is shown
in the box incorporating the leading edge of the anterior mitral leaflet. Any fibrous and/or muscular attachments that
occur between the side of the anterior mitral leaflet or subvalvar apparatus that are attached to the ventricular septum
or free wall are incised. This will not result in mitral regurgitation as long as all of the chordal attachments to the leading
edge of the valve are preserved. Residual strands of fibrous connections are excised at the base of their site of origin so
that small mobile chordae are not seen on the postmyectomy TEE examination. (B) Completed extended left ventricular
septal myectomy in addition to resection of abnormal chordal attachments.
TFigure 14 This figure demonstrates an example of an accessory papillary muscle which arises from the ventricular
septum. The fibrous attachments to the side of the anterior mitral leaflet can be seen. This muscle contributes to LVOT
ransaortic septal myectomy 291obstruction because of its presence in the LVOT throughout the cardiac cycle.
Figure 15 This accessory muscle is excised in its entirety. The fibrous attachments to the side of the leaflet are cut and
the papillary muscle is amputated at its base and removed (dotted line). All of these procedures with an abnormal
subvalvar apparatus are done in conjunction with the extended left ventricular septal myectomy. Midventricular
obstruction can also be a result of severe hypertrophy of the papillary muscles; additional resection is then performed
by shaving the sides of the papillary muscles and resecting obstructing tissue around their bases.
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292 J.A. Dearani and G.K. Danielsonxperience at the Mayo Clinic
ince 1959, more than 700 patients have had septal my-
ctomy for HCM at the Mayo Clinic. Data from a retro-
pective review of 199 patients have been reported.18 Ages
anged from 2 months to 80 years (median, 45 years).
reoperative NYHA class was III/IV in 120 patients (60%).
itral valve regurgitation was moderate to severe in 108
atients (54%). Median resting LVOT gradient was 85
mHg. Ninety patients (45%) required additional cardiac
rocedures including division of abnormal mitral papil-
ary muscle attachments (n  20), mitral valve replace-
ent (n  5), and other (n  65). Median intraoperative
ostmyectomy LVOT gradient was 4 mmHg. Postopera-
ive mitral regurgitation was moderate in 16 patients (8%).
ermanent heart block occurred in two patients (1%). No
arly deaths occurred in the 109 patients undergoing iso-
ated myectomy. There were three early deaths in patients
ndergoing associated cardiac procedures (overall early
ortality 1.5%). Follow-up in 178 patients (91%) ranged
p to 23 years (median, 4 years). Overall survival was 91
3% at 5 years and 83  4% at 10 years. Median resting
VOT gradient on follow-up echocardiography in 121 pa-
ients (68%) was 5 mmHg (Fig 7). Follow-up NYHA class
as I/II in 127 patients (81%).
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